Clinical Trial Update: Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combined antioxidant therapy for diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: University of Guadalajara | Conditions: Diabetic Retinopathy | Phase 3 | Status: COMPLETED